B3GNT2 / B3GALT7 antibody
Principal name
B3GNT2 / B3GALT7 antibody
Alternative names for B3GNT2 / B3GALT7 antibody
BGnT-1, Beta-1,3-GalTase 7, Beta3Gal-T7, b3Gal-T7, B3GNT1, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, Beta3Gn-T1, Beta-1,3-galactosyltransferase 7, Beta-3-Gx-T7, UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 7, UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7, UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of B3GNT2 / B3GALT7 antibody
- Kit Component:
- - KN208100G1, B3GNT1 gRNA vector 1 in pCas-Guide vector
- KN208100G2, B3GNT1 gRNA vector 2 in pCas-Guide vector
- KN208100D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Hayashi N, Nakamori S, Okami J, Nagano H, Dono K, Umeshita K, Sakon M, Narimatsu H, Monden M.
Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue.
Pathobiology. 2004;71(1):26-34.
PMID: 14555842.












- Quick-Filters:
- Highly Validated (2)
Primary Antibodies
Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
---|---|---|---|---|---|---|---|
TA505270 | B3GNT2 / B3GALT7 antibody |
||||||
B3GNT2 mouse monoclonal antibody, clone OTI1G10 (formerly 1G10) | |||||||
![]() |
Mouse | IgG2a | OTI1G10 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€350.00
|
OriGene Technologies, Inc. | |||||||
![]() |
Highly validated antibody! |
||||||
TA505283 | B3GNT2 / B3GALT7 antibody |
||||||
B3GNT2 mouse monoclonal antibody, clone OTI3A9 (formerly 3A9) | |||||||
![]() |
Mouse | IgG2a | OTI3A9 | Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€379.00
|
OriGene Technologies, Inc. | |||||||
![]() |
Highly validated antibody! |
||||||
TA303284 | B3GNT2 / B3GALT7 antibody |
||||||
Goat Polyclonal Antibody against B3GNT2 | |||||||
![]() |
Goat | Aff - Purified | Hu, Ms, Rt | WB |
0.1 mg /
€360.00
|
||
OriGene Technologies, Inc. | |||||||
TA505331 | B3GNT2 / B3GALT7 antibody |
||||||
B3GNT2 mouse monoclonal antibody, clone OTI4B9 (formerly 4B9) | |||||||
![]() |
Mouse | IgG2a | OTI4B9 | Purified | Hu | ICC/IF, WB |
0.1 ml /
€350.00
|
OriGene Technologies, Inc. | |||||||
![]() |
CRISPR
Catalog No. | Species | Donor Vector | |
---|---|---|---|
KN208100 | B3GNT2 - human gene knockout kit via CRISPR |
||
![]() |
Human | GFP-Puro |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. | |||
KN208100BN | B3GNT2 - human gene knockout kit via CRISPR |
||
![]() |
Human | mBFP-Neo |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. | |||
KN208100LP | B3GNT2 - human gene knockout kit via CRISPR |
||
![]() |
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. | |||
KN208100RB | B3GNT2 - human gene knockout kit via CRISPR |
||
![]() |
Human | RFP-BSD |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. |
Proteins & Growth Factors
Catalog No. | Species | Pres. | Purity | Source | |
---|---|---|---|---|---|
TP308100 | B3GNT2 / B3GALT7 |
||||
Recombinant protein of human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
OriGene Technologies, Inc. | |||||
Lysates
Catalog No. | ||
---|---|---|
LY416552 | B3GNT2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
OriGene Technologies, Inc. |
Human Lenti ORF Particles
Catalog No. | ||
---|---|---|
RC208100L2V | Lenti ORF particles, B3GNT2 (mGFP-tagged) - Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,082.00
|
|
OriGene Technologies, Inc. | ||
RC208100L1V | Lenti ORF particles, B3GNT2 (Myc-DDK tagged) - Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2) , 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€969.00
|
|
OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
Catalog No. | ||
---|---|---|
MR206220L2V | Lenti ORF particles, B3gnt2 (GFP-tagged) - Mouse UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3gnt2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,206.00
|
|
OriGene Technologies, Inc. | ||
MR206220L1V | Lenti ORF particles, B3gnt2 (Myc-DDK-tagged) - Mouse UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3gnt2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,082.00
|
|
OriGene Technologies, Inc. | ||